Skip to main content Skip to main navigation menu Skip to site footer

The potential application of conditioned media-mesenchymal stem cells on human oocyte maturation in assisted reproductive technology: a quasi-experimental based-study at Dr. Sardjito General Hospital, Yogyakarta, Indonesia

  • Dwi Haryadi ,
  • Ahmad Hamim Sadewa ,
  • Sofia Mubarika ,
  • Djaswadi Dasuki ,


Background: PCOS typically characterized by a decreased level of GDF9 and BMP15, which contribute to follicular arrest. Recent research related to stem cells showed that conditioned media-mesenchymal stem cell (CM-MSC) might have a positive role in folliculogenesis. Therefore, this study aimed to assess the effectiveness of CM-MSC towards oocyte maturity

Method: A quasi-experimental design was used to examine the outcome of 3 different interventions, namely group A (4-hour incubation in standard media), group B (24-hour incubation in standard media), and group C (24 hours incubation in conventional media with addition of CM-MSC). Nuclear and cytoplasmic maturity, along with GDF9 and BMP15 levels were measured and analyzed.

Results: Sixty-three patients at an infertility clinic, RSUP Dr. Sardjito, Yogyakarta was recruited and a total of 292 germinal vesicles were obtained to start in vitro maturation procedure. Multivariate analysis showed group C has OR 6.9 (3,3–14,41) to obtain metaphase II oocyte than group B (p <0,0001). Infertility causes, insulin resistance, and maternal age risk are other factors that significantly influence oocyte maturity outcome (p <0.001; p = 0.005; p = 0.017). For the oocyte morphology outcome, no significant effect was obtained from the intervention (p> 0.05). Group C has higher GDF9 levels (Δ mean = 3.31) and BMP15 (Δ mean = 1.52) compared with group B (p <0.001; p = 0.006).

Conclusion: It can be concluded that 24-hour incubation in CM-MSC was effective to induce oocyte maturation. However, other factors, such as infertility causes, insulin resistance, and maternal age, should also be considered.


  1. Bennett L, Wiweko B, Hinting A, Adnyana I, Pangestu M. Indonesian infertility patients’ health seeking behaviour and patterns of access to biomedical infertility care: an interviewer administered survey conducted in three clinics. Reproductive Health. 2012;9(1).
  2. Cano F, García-Velasco J, Millet A, Remohí J, Simón C, Pellicer A. Oocyte quality in polycystic ovaries revisited: Identification of a particular subgroup of women. Journal of Assisted Reproduction and Genetics. 1997;14(5):254-261.
  3. Urman B, Tiras B, Yakin K. Assisted reproduction in the treatment of polycystic ovarian syndrome. Reproductive BioMedicine Online. 2004;8(4):419-430.
  4. De Vos A, Van de Velde H, Joris H, Van Steirteghem A. In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection. Human Reproduction. 1999;14(7):1859-1863.
  5. Lee H, Barad D, Kushnir V, Shohat-Tal A, Lazzaroni-Tealdi E, Wu Y et al. Rescue in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR). Endocrine. 2015;52(1):165-171.
  6. He A, Wang S, Chen T, Li J, Liu X. Biological Characteristics of MSCs. Advanced Topics in Science and Technology in China. 2009;:19-58.
  7. Laqif A. Kajian Terapi Media Terkondisi Sel Punca Mesensimal (MT-SPM) Selaput Amnion pada Kasus Kegagalan Ovarium Prematur (Penelitian pada Hewan Coba Tikus Sprague-Dawley) [Ph.D]. Gadjah Mada University; 2015.
  8. da Silva Meirelles L, Fontes A, Covas D, Caplan A. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & Growth Factor Reviews. 2009;20(5-6):419-427.
  9. McNatty K, Moore L, Hudson N, Quirke L, Lawrence S, Reader K et al. The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction. 2004;128(4):379-386.
  10. Rienzi L, Vajta G, Ubaldi F. Predictive value of oocyte morphology in human IVF: a systematic review of the literature. Human Reproduction Update. 2010;17(1):34-45.
  11. Akbari H, Eftekhar Vaghefi SH, Shahedi A, et al. Mesenchymal Stem Cell-Conditioned Medium Modulates Apoptotic and Stress-Related Gene Expression, Ameliorates Maturation and Allows for the Development of Immature Human Oocytes after Artificial Activation. Genes (Basel). 2017;8(12):371. Published 2017 Dec 8. doi:10.3390/genes8120371
  12. Ling B, Feng DQ, Zhou Y, Gao T, Wei HM, Tian ZG. Effect of conditioned medium of mesenchymal stem cells on the in vitro maturation and subsequent development of mouse oocyte. Braz J Med Biol Res. 2008 Nov;41(11):978-85.
  13. Miraki S, Mokarizadeh A, Banafshi O, et al. Embryonic Stem Cell Conditioned Medium Supports In Vitro Maturation of Mouse Oocytes. Avicenna J Med Biotechnol. 2017;9(3):114–119.
  14. Maldonado M, Huang T, Chen J, Zhong Y. Differentiation Potential of Human Wharton's Jelly-Derived Mesenchymal Stem Cells and Paracrine Signaling Interaction Contribute to Improve the In Vitro Maturation of Mouse Cumulus Oocyte Complexes. Stem Cells Int. 2018;2018:7609284. Published 2018 Oct 11. doi:10.1155/2018/7609284
  15. Sakaguchi M, Dominko T, Leibfried-Rutledge ML, Nagai T, First NL. A combination of EGF and IGF-I accelerates the progression of meiosis in bovine follicular oocytes in vitro and fetal calf serum neutralizes the acceleration effect. Theriogenology 2000; 54: 1327-1342.
  16. Sakaguchi M, Dominko T, Yamauchi N, Leibfried-Rutledge ML, Nagai T, First NL. Possible mechanism for acceleration of meiotic progression of bovine follicular oocytes by growth factors in vitro. Reproduction 2002; 123: 135-142

How to Cite

Haryadi, D., Sadewa, A. H., Mubarika, S., & Dasuki, D. (2019). The potential application of conditioned media-mesenchymal stem cells on human oocyte maturation in assisted reproductive technology: a quasi-experimental based-study at Dr. Sardjito General Hospital, Yogyakarta, Indonesia. Bali Medical Journal, 8(3), 741–748.




Search Panel